Brief: Cereno Expands Patent Protection For Epigenetic HDAC Inhibitor CS1:s Second Patent Family

Cereno Scientific AB

11/04/2024 07:33

April 11 (Reuters) - Cereno Scientific AB  CRNOSb.ST :
    * EXPANDS PATENT PROTECTION FOR EPIGENETIC HDAC INHIBITOR
CS1:S
SECOND PATENT FAMILY
    * PATENT IS VALID THROUGH 2035, WITH OPTION TO EXTEND IT FOR
UP TO
FIVE YEARS
    * SECOND PATENT FAMILY PREVIOUSLY OBTAINED PATENTS IN
AUSTRALIA,
CANADA, EUROPE, JAPAN, ISRAEL, MALAYSIA, MEXICO, RUSSIA AND USA

Source text for Eikon:  ID:nWkr8KfCXK 
Further company coverage:  CRNOSb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))